×
When lockdown policies amplify social inequalities in COVID-19 infections: evidence fro...
https://doi.org/10.1186/s12889-021-10521-5 10.1016/j.annepidem.2016.02.003 10.1371/journal.pone.0232452 10.1186/s12939-020-01218-z 10.1038/s41591-020-0823-6 10.1136/jech-2020-214297 10.1007/s10654-015-0096-4 10.1136/bmjopen-2020-039652 10.7326/M20-0504 10.1080/01621459.1993.10476369 10.1001/jamanetworkopen.2020.16099 10.1016/S0140-6736(20)31483-5 10.1186/s12916-020-01640-8 10.1111/1467-8322.12571 10.1016/S0140-6736(20)30757-1 10.1136/bmj.m2149 10.1111/1475-5890.12232 10.1007/s00148-020-00799-x
BMC Public Health; Bajos N, Jusot F et. al.

Apr 13th, 2021 - Significant differences in COVID-19 incidence by gender, class and race/ethnicity are recorded in many countries in the world. Lockdown measures, shown to be effective in reducing the number of new cases, may not have been effective in the same way for all, failing to protect the most vulnerable populations. This survey aims to assess social inequalities in the trends in COVID-19 infections fol...

Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomise...
https://doi.org/10.1016/j.amjoto.2021.103033
American Journal of Otolaryngology; Rashid RA, Zgair A et. al.

Apr 11th, 2021 - Anosmia is a common debilitating symptom of the novel coronavirus disease 2019 (COVID-19). Currently, there is no satisfactory treatment of anosmia. Therefore, this study was conducted to evaluate the therapeutic effect of nasal betamethasone drops in the recovery of olfaction in COVID-19-associated anosmia. The study was designed as a randomised, double-blind, placebo-controlled clinical trial...

Re-initiation of CT colonography services during the COVID-19 pandemic: Preliminary eva...
https://doi.org/10.1259/bjr.20201316
The British Journal of Radiology; Peprah D, Plumb A et. al.

Apr 9th, 2021 - The COVID-19 pandemic has led to cancellation and deferral of many cancer investigations, including CT colonography (CTC). In May 2020, BSGAR and SCoR issued guidelines outlining steps for conduct of CTC in the early recovery phase. We evaluated the implementation of these in four English hospital trusts. Ethical permission was not required for this multicentre service evaluation. We identified...

Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City.
https://doi.org/10.1371/journal.pone.0247433
PloS One; Flores-Silva FD, García-Grimshaw M et. al.

Apr 8th, 2021 - The coronavirus disease 2019 (COVID-19) is a systemic entity that frequently implies neurologic features at presentation and complications during the disease course. We aimed to describe the characteristics and predictors for developing in-hospital neurologic manifestations in a large cohort of hospitalized patients with COVID-19 in Mexico City. We analyzed records from consecutive adult patien...

COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eo...
https://doi.org/10.1177/19458924211004800
American Journal of Rhinology & Allergy; Sehanobish E, Barbi M et. al.

Apr 5th, 2021 - Anosmia and ageusia are symptoms commonly associated with COVID-19, but the relationship with disease severity, onset and recovery are unclear. To examine factors associated with anosmia and ageusia and the recovery from these symptoms in an ethnically diverse cohort. Individuals tested for SARS-CoV-2 between March and April 2020 were eligible for the study. Randomly selected participants answe...

Simultaneously Complete but Not Partial Taste and Smell Losses were Associated with SAR...
https://doi.org/10.1016/j.ijid.2021.03.083
International Journal of Infectious Diseases : IJID : Off... Trachootham D, Thongyen S et. al.

Apr 5th, 2021 - To investigate the association between taste and smell losses and SAR-CoV-2 infection, and elucidate whether taste preference influences such taste loss METHODS: A matched case-control study was conducted in 366 Thais including RT-PCR confirmed SAR-CoV-2 positive (n = 122, Case) and negative (n = 244, Control) groups. Taste, smell and appetite changes were assessed by self-reported visual analo...

Recovery rate and factors associated with smell and taste disruption in patients with c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358151
American Journal of Otolaryngology; Parente-Arias P, Barreira-Fernandez P et. al.

Apr 2nd, 2021 - To determine the occurrence of olfactory and gustatory disruptions in COVID-19 patients, their association with demographic and clinical features and prognosis. This observational cohort study involved consecutively diagnosed COVID-19 patients tested between March the 3rd 2020 and March the 24th 2020, in a geographically defined cohort area. All COVID-19 patients were evaluated in a University ...

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009612
Lancet (London, England); Emary KRW, Golubchik T et. al.

Apr 2nd, 2021 - A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this variant. Volunteers (aged ≥18 years) who were enrolled in phase 2/3 vaccine efficacy studies in the UK, and who were randomly assigned (1:1) to receive ChAdOx...

Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988684
BMC Infectious Diseases; Werner J, Reichen I et. al.

Mar 25th, 2021 - Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is spreading globally and causes most frequently fever and respiratory symptoms, i.e. Coronavirus disease 2019 (COVID-19), however, distinct neurological syndromes associated with SARS-CoV-2 infection have been described. Among SARS-CoV-2-infections-associated neurological symptoms fatigue, headache, dizziness, impaired consciousness and an...

Concomitant Guillain-Barre syndrome with COVID-19: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985584
BMC Neurology; Mackenzie N, Lopez-Coronel E et. al.

Mar 24th, 2021 - During the Coronavirus disease 2019 (COVID-19) pandemic, different neurological manifestations have been observed. However, only a few cases of Guillain-Barre syndrome (GBS) and COVID-19 have been reported. Therefore, the aim of this study is to investigate a case of concomitant GBS with COVID-19 in Colombia. A 39-year-old woman was admitted to a teaching hospital in Barranquilla, Colombia with...

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based p...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990210
PloS One; Dixon BE, Wools-Kaloustian KK et. al.

Mar 24th, 2021 - Prior studies examining symptoms of COVID-19 are primarily descriptive and measured among hospitalized individuals. Understanding symptoms of SARS-CoV-2 infection in pre-clinical, community-based populations may improve clinical screening, particularly during flu season. We sought to identify key symptoms and symptom combinations in a community-based population using robust methods. We pooled c...

Optic neuritis following SARS-CoV-2 infection.
https://doi.org/10.1007/s13365-021-00959-z 10.1136/jnnp-2014-310206 10.1080/09273948.2020.1792512 10.1038/s41564-020-0695-z 10.1097/WNO.0000000000001039 10.1212/WNL.0000000000009700 10.1016/S1474-4422(20)30221-0 10.1212/WNL.0000000000009619 10.1212/NXI.0000000000000163 10.1007/s10571-020-00947-7 10.1016/j.msard.2020.102377 10.1136/jnnp-2017-316880 10.1097/WNO.0000000000001049 10.1001/jamaneurol.2020.2065
Journal of Neurovirology; Rodríguez-Rodríguez MS, Romero-Castro RM et. al.

Mar 23rd, 2021 - The most common neurologic symptoms in COVID-19 are headache, anosmia, and dysgeusia. Optic neuritis is an unusual manifestation of SARS-CoV-2 infection. We report a case of a patient who initially consulted for vision loss in the absence of respiratory symptoms. She was diagnosed with optic neuritis following SARS-CoV-2 infection. Delay in diagnosis of neuro-ophthalmic manifestations of COVID-...

Anti-biofilm topical therapy in rhinosinusitis, coronavirus in India, anosmia prognosis...
https://doi.org/10.1017/S0022215121000761
The Journal of Laryngology and Otology; Fisher EW, Fishman J

Mar 23rd, 2021 - Anti-biofilm topical therapy in rhinosinusitis, coronavirus in India, anosmia prognosis, fish bones and flexible laryngoscopy.|2021|Fisher EW,Fishman J,|epidemiology,therapy,epidemiology,therapy,therapy,

Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962915
International Journal of Infectious Diseases : IJID : Off... Alkindi S, Elsadek RA et. al.

Mar 20th, 2021 - The aim of this study was to assess the impact of COVID-19 on the morbidity and mortality on vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients. One hundred patients with(fifty) or without COVID-19 PCR positivity(fifty), were enrolled in a prospective cohort study after signing a written informed consent. The COVID-19 positive patients had significantly higher median VOC episodes/y...

Clinical Features and Risk Factors Associated with Morbidity and Mortality Among COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962557
International Journal of Infectious Diseases : IJID : Off... Abraha HE, Gessesse Z et. al.

Mar 20th, 2021 - To describe clinical features and assess determinants of severity and in-hospital mortality of COVID-19 patients from unique setting in Ethiopia. Consecutive patients admitted to COVID-19 quarantine and isolation center were included. We analyzed proportions of clinical spectrum of COVID-19, factors associated with risk of severe COVID-19 and in-hospital mortality. Of 2617 patients, three-quart...

Comparative Study of Chemosensory Dysfunction in COVID-19 in 2 Geographically Distinct ...
https://doi.org/10.1177/01455613211000170
Ear, Nose, & Throat Journal; Lee DJ, Daliyot D et. al.

Mar 17th, 2021 - To directly compare the prevalence of chemosensory dysfunction (smell and taste) in geographically distinct regions with the same questionnaires. A cross-sectional study was performed to evaluate the self-reported symptoms among adults (older than 18 years) who underwent COVID-19 testing at an ambulatory assessment center in Canada and at a hospital in Israel between March 16, 2020, and August ...

Neurological manifestations as the predictors of severity and mortality in hospitalized...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960879
BMC Neurology; Amanat M, Rezaei N et. al.

Mar 17th, 2021 - The reports of neurological symptoms are increasing in cases with coronavirus disease 2019 (COVID-19). This multi-center prospective study was conducted to determine the incidence of neurological manifestations in hospitalized cases with COVID-19 and assess these symptoms as the predictors of severity and death. Hospitalized males and females with COVID-19 who aged over 18 years were included i...

Optic nerve and macular optical coherence tomography in recovered COVID-19 patients.
https://doi.org/10.1177/11206721211001019
European Journal of Ophthalmology; Burgos-Blasco B, Güemes-Villahoz N et. al.

Mar 15th, 2021 - To investigate the peripapillary retinal nerve fiber layer thickness (RNFLT), macular RNFLT, ganglion cell layer (GCL), and inner plexiform layer (IPL) thickness in recovered COVID-19 patients compared to controls. Patients previously diagnosed with COVID-19 were included, while healthy patients formed the historic control group. All patients underwent an ophthalmological examination, including...

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies...
https://doi.org/10.1097/WCO.0000000000000930
Current Opinion in Neurology; Schweitzer F, Kleineberg NN et. al.

Mar 12th, 2021 - To provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest management concepts. Headache, dizziness, excessive tiredness, myalgia, anosmia/hyposmia, and ageusia/dysgeusia are common nonspecific neurological manifestations during early COVID-19 disease found in the majority of patients. Less frequent but more severe and specific neurologica...

Diagnostic accuracy of symptoms as a diagnostic tool for SARS-CoV 2 infection: a cross-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947944
BMC Infectious Diseases; Romero-Gameros CA, Colin-Martínez T et. al.

Mar 12th, 2021 - The SARS-CoV-2 pandemic continues to be a priority health problem; According to the World Health Organization data from October 13, 2020, 37,704,153 confirmed COVID-19 cases have been reported, including 1,079,029 deaths, since the outbreak. The identification of potential symptoms has been reported to be a useful tool for clinical decision-making in emergency departments to avoid overload and ...